Tag
GSK expands its $110M AI drug discovery partnership with Relation Therapeutics, emphasizing that clean, disease-specific biological data from lab experiments is more valuable than larger models. The move highlights an industry-wide pivot toward proprietary data as a competitive moat in AI-driven pharma.